Intrinsic Value of S&P & Nasdaq Contact Us

Illumina, Inc. ILMN NASDAQ

NASDAQ Global Select • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
61/100
4/7 Pass
SharesGrow Intrinsic Value
$143.90
+10.4%
Analyst Price Target
$147.13
+12.9%

Stock Statistics — ILMN

Illumina, Inc. (ILMN) has a market capitalization of $19.93B and trades at $130.32. The 52-week range is 68.7-155.53.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 23.8, Earnings Per Share (EPS) of $5.47, annual revenue of $4.34B.

The stock has a beta of 1.49, operates in the Healthcare sector.

Trading Data
Current Price$130.32
52-Week Range68.7-155.53
Volume1.19M
Avg Volume (30D)1.97M
Market Cap$19.93B
Beta (1Y)1.49
Company
IPO Date2000-07-28
Employees8,970
CEOJacob Thaysen
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS4523271090
CUSIP452327109
Income (Latest Year)
Revenue$4.34B
Gross Profit$2.89B
EBITDA$1.46B
Operating Income$865M
Net Income$850M
EPS$5.47
EPS Diluted$5.44
Shares Outstanding$153M
Balance Sheet (Latest Year)
Total Assets$6.64B
Current Assets$3.29B
Cash & ST Investments$1.63B
Total Liabilities$3.92B
Total Debt$2.55B
Net Debt$1.14B
Total Equity$2.72B
Debt / Equity0.94
Valuation Ratios
P/E Ratio23.8
P/S Ratio4.59
P/B Ratio7.32
EV/EBITDA (approx)13.7
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message